Cencora, Inc. (COR)

Theseus Pharmaceuticals Revenue

Cencora had revenue of $80.66B in the quarter ending June 30, 2025, with 8.65% growth. This brings the company's revenue in the last twelve months to $316.65B, up 11.56% year-over-year. In the fiscal year ending September 30, 2024, Cencora had annual revenue of $293.96B with 12.12% growth.

• Revenue (ttm): $316.65B
• Revenue Growth: +11.56%
• P/S Ratio: 0.18
• Revenue / Employee: $6,883,791
• Employees: 46,000
• Market Cap: 55.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	293.96B	31.79B	12.12%
Sep 30, 2023	262.17B	23.59B	9.89%
Sep 30, 2022	238.59B	24.60B	11.50%
Sep 30, 2021	213.99B	24.09B	12.69%
Sep 30, 2020	189.89B	10.30B	5.74%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.